The Leukemia & Lymphoma Society's On Target For A Cure Clay Tournament Raises $280,000 for Cancer Research and Patient Aid
Posted on: Wednesday, 15 November 2006, 12:00 CST
DALLAS, Nov. 15 /PRNewswire/ -- The Leukemia & Lymphoma Society's On Target For A Cure Sporting Clays Tournament was a huge success, raising $280,000 for blood cancer research, patient aid and education. The three-day tournament began with a sporting dinner on Thursday, October 12 at the Frontiers of Flight Museum in Dallas. Over 180 patrons and underwriters attended the dinner, complete with a cocktail reception and live auction. Featured auction items included amazing donated items such as diamond earrings and a safari in Africa. The tournament continued on Friday at Elm Fork Shotgun Sports, where $7,500 and up sponsors practiced on the shooting range one day prior to the actual tournament. On Saturday, the event concluded after an all-day clay shoot-out, followed by a demonstration by All-American Beretta Athlete Scott Robertson. Craig Cooper claimed first place with a score of 97, while Rick Benners shot a 94 for 2nd place. Third place went to John Rubi, scoring 89.
Tina Garcia, Executive Director of The Leukemia & Lymphoma Society's North Texas chapter, said, "The tournament was a huge success due to the outstanding support of our underwriters and a very dedicated planning committee." Platinum sponsors included Kathi and Scott Shuford of the Dallas Auction Gallery, Land Rover Dallas and a personal contribution from Maura and Tim Costello. Among many other sponsors, American Airlines and Laser Spine Institute, Inc. also contributed to the event.
About The Leukemia & Lymphoma Society -- The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The society's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and to improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $483 million for research specifically targeting blood cancers to over 425 researchers in 120 institutions worldwide. Society-funded research has led to key advances in understanding blood cancers and has produced new treatments to enhance and prolong lives. Innovations in cancer treatment over the years have included radiation and chemotherapy, stem cell transplantation and new targeted therapies that kill cancer cells without harming normal cells.
The Leukemia & Lymphoma Society
CONTACT: Jason Vincik, Marketing & Public Relations Manager of TheLeukemia & Lymphoma Society, +1-972-354-8315, or vincikJ@lls.org
Source: PRNewswire
Related Articles
- FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
- The Leukemia & Lymphoma Society Awards Major Grant to Stanford Researcher
- Toddler Receives Own Umbilical Cord Blood As Cancer Treatment
- American Cancer Society Honors Outstanding Contributions to Fight Against Cancer
- Immunomedics to Be Awarded U.S. Patent for the Treatment of B-Cell Lymphomas, Leukemias and Autoimmune Diseases
- Quest Diagnostics Launches the First Tests to Help Doctors Assess Status of Leukemia and Lymphoma in Patients Using Blood Plasma Instead of Bone Marrow
- Blood Research Foundation Awarded $1.35 Million Grant
- The Leukemia & Lymphoma Society Unveils National Education Program For Elderly Cancer Patients
- North Texas' Top Hematology/Oncology Specialists to Speak at The Leukemia & Lymphoma Society's First Annual Lone Star Blood Cancer Conference
- San Diego Medical Conference Highlights Research of Blood-Related Cancers
 |
 |
User Comments (0)
RSS Feeds